Use access key #2 to skip to page content.
$19.82 -0.64 (-3.13%)
8/21/2008 4:00 PM

Schering-Plough Corp (SGP)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.

View All Commentary (SGP)

Recs

0

Avatar juanocb12 (86.38) Submitted: 4/03/08 8:23 AM : Outperform Start Price: $13.97 SGP Score: 47.95

Went down becuase of the Vytorin. Sould go back up once it redevelops the formula. The good thing this incident is that it was a joint venture greatly minimizing risks.

Report this Post Replies: 0 | Reply

Featured Broker Partners